Literature DB >> 7341494

The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents.

F Majewski, M Steger, B Richter, J Gill, F Rabe.   

Abstract

A total of 194 children of epileptic mothers and 71 children of epileptic fathers were examined for mental retardation, neurologic disturbances, major malformations, and acrofacial dysmorphias typical for hydantoin-barbiturate embryopathy (HB-E). HB-E was observed in nearly 7% of the children of mothers on anticonvulsants during pregnancy. Barbiturates and/or primidone were observed to induce the same dysmorphic features as hydantoins. The teratogenic potential of hydantoins may be slightly increased in combination with barbiturates/primidone. Neither the 71 children of epileptic fathers nor the 46 children of epileptic mothers without anticonvulsants exhibited symptoms of HB-E. The frequency of major, unspecific malformations was increased in children of epileptic mothers as well as in children of epileptic fathers as compared with the general population. Cerebral disturbances without dysmorphias were increased in children of mothers with and without anticonvulsants, but this was rarely the case in children of epileptic fathers. Cerebral disturbances were observed more often in children of mothers with seizures during pregnancy than in children of mothers without seizures. Multifactorial genetic influences on major malformations and influences of maternal seizures on cerebral disturbances in the offspring are likely.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7341494

Source DB:  PubMed          Journal:  Int J Biol Res Pregnancy        ISSN: 0173-8593


  8 in total

Review 1.  Treatment of epilepsy in pregnancy.

Authors:  I Nulman; D Laslo; G Koren
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

2.  Additional educational needs in children born to mothers with epilepsy.

Authors:  N Adab; A Jacoby; D Smith; D Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

Review 3.  Antiepileptic drugs and neurodevelopment: an update.

Authors:  Susan Palac; Kimford J Meador
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 4.  Neurodevelopmental effects of antiepileptic drugs.

Authors:  Kimford J Meador
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

5.  The longer term outcome of children born to mothers with epilepsy.

Authors:  N Adab; U Kini; J Vinten; J Ayres; G Baker; J Clayton-Smith; H Coyle; A Fryer; J Gorry; J Gregg; G Mawer; P Nicolaides; L Pickering; L Tunnicliffe; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 6.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Malformation rates in children of women with untreated epilepsy: a meta-analysis.

Authors:  Shawn Fried; Eran Kozer; Irena Nulman; Thomas R Einarson; Gideon Koren
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 8.  Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.

Authors:  Rebecca Bromley; Jennifer Weston; Naghme Adab; Janette Greenhalgh; Anna Sanniti; Andrew J McKay; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2014-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.